| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CRESCENT BIOPHARMA, INC. | Treasurer, Senior Vice President of Finance and Chief Accounting Officer. | Ordinary Shares | 12,378 | $186,660 | $15.08 | 15 Dec 2025 | Direct |
| CRESCENT BIOPHARMA, INC. | Treasurer, Senior Vice President of Finance and Chief Accounting Officer. | Stock Option (Right to Buy) | 33,512 | 15 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GLYC | CRESCENT BIOPHARMA, INC. | 15 Dec 2025 | 3 | $0 | 4 | Treasurer, Senior Vice President of Finance and Chief Accounting Officer. | 17 Dec 2025, 16:38 |
| GLYC | GLYCOMIMETICS INC | 13 Jun 2025 | 0 | $0 | 3 | Treasurer, Senior Vice President of Finance and Chief Accounting Officer. Exhibit 24 - Power of Attorney | 23 Jun 2025, 18:29 |